| 000 | 01857 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515044144.0 | ||
| 264 | 0 | _c20070215 | |
| 008 | 200702s 0 0 eng d | ||
| 022 | _a1538-7933 | ||
| 024 | 7 |
_a10.1111/j.1538-7836.2006.02265.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBallerio, R | |
| 245 | 0 | 0 |
_aDistinct roles for PAR1- and PAR2-mediated vasomotor modulation in human arterial and venous conduits. _h[electronic resource] |
| 260 |
_bJournal of thrombosis and haemostasis : JTH _cJan 2007 |
||
| 300 |
_a174-80 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aCoronary Artery Bypass _xmethods |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMammary Arteries _xdrug effects |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
| 650 | 0 | 4 |
_aOligopeptides _xpharmacology |
| 650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
| 650 | 0 | 4 |
_aReceptor, PAR-1 _xagonists |
| 650 | 0 | 4 |
_aReceptor, PAR-2 _xagonists |
| 650 | 0 | 4 | _aResearch Design |
| 650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
| 650 | 0 | 4 |
_aSaphenous Vein _xdrug effects |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xpharmacology |
| 650 | 0 | 4 |
_aVasodilation _xdrug effects |
| 700 | 1 | _aBrambilla, M | |
| 700 | 1 | _aColnago, D | |
| 700 | 1 | _aParolari, A | |
| 700 | 1 | _aAgrifoglio, M | |
| 700 | 1 | _aCamera, M | |
| 700 | 1 | _aTremoli, E | |
| 700 | 1 | _aMussoni, L | |
| 773 | 0 |
_tJournal of thrombosis and haemostasis : JTH _gvol. 5 _gno. 1 _gp. 174-80 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1538-7836.2006.02265.x _zAvailable from publisher's website |
| 999 |
_c16634347 _d16634347 |
||